Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30− Tumors
Hombach, Andreas A., Rappl, Gunter and Abken, Hinrich (2019) Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30− Tumors. Molecular Therapy 27 (10), pp. 1825-1835.Date of publication of this fulltext: 03 Sep 2021 09:42
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Molecular Therapy | ||||
| Publisher: | CELL PRESS | ||||
|---|---|---|---|---|---|
| Place of Publication: | CAMBRIDGE | ||||
| Volume: | 27 | ||||
| Number of Issue or Book Chapter: | 10 | ||||
| Page Range: | pp. 1825-1835 | ||||
| Date | 2019 | ||||
| Institutions | Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | ANTIIDIOTYPE VACCINE; HODGKINS LYMPHOMA; SPACER DOMAIN; B-CELL; EXPRESSION; RECEPTOR; ACTIVATION; IL-4; PROLIFERATION; CONSTRUCTION; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48156 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric